The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.

New Peripheral Line Draw Solution Delivers First and Only Compatibility with Integrated Catheters, Bringing Elevated Standard of Care to More U.S. Hospitals With 510(k) clearance from the U.S. Food ...

SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the launch of its next generation technology for dried blood ...

The Plasmapheresis Market has been gaining notable momentum in the global healthcare sector due to the rising prevalence of ...